Regeneron Pharmaceuticals, Inc. vs Phillips 66
Confronto della capitalizzazione di mercato nel tempo
Regeneron Pharmaceuticals, Inc.
$68.6B
Posizione #236
Phillips 66
$70.7B
Posizione #232
Capitalizzazione di mercato nel tempo
Momenti chiave
- Phillips 66 ha superato Regeneron Pharmaceuticals, Inc. entro il 2026
Confronto anno per anno
| Anno | Regeneron Pharmaceuticals, Inc. | Phillips 66 | Leader |
|---|---|---|---|
| 2026 | $68.6B | $70.7B | Phillips 66 |
| 2025 | $79.3B | $50.9B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $72.8B | $43.4B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $89.7B | $49.1B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.7B | $36.9B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $64.5B | $24.6B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $49.4B | $22.7B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $38.4B | $34.3B | Regeneron Pharmaceuticals, Inc. |
| 2018 | $38.2B | $25.6B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $38.4B | $29.2B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $37.5B | $24.2B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $55.5B | $22.2B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $41.9B | $18.9B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $28.1B | $19.9B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $17.5B | $13.4B | Regeneron Pharmaceuticals, Inc. |